ArticleJMIR public health and surveillance2025
Perceptions of Long-Acting Injectable Pre-Exposure Prophylaxis Among Men Who Have Sex With Men and Transgender Individuals in Europe Using Structural Text Modeling Technique: Cross-Sectional Study.
Article in JMIR public health and surveillance, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Epidemiologic Impact of Prioritizing Long-Acting Injectable Cabotegravir to Men Who Have Sex With Men With Low Pre-Exposure Prophylaxis Use Adherence in the Netherlands: A Mathematical Modeling Study.Journal of acquired immune deficiency syndromes (1999) · 2026Article
- Awareness, Usage and Perceptions of Doxycycline Post-Exposure Prophylaxis (doxyPEP) for Prevention of Sexually Transmitted Infections in Australia: Insights From a National Cross-Sectional Survey.The Medical journal of Australia · 2026Article
- The unseen impact of affordability: copayment sensitivity for long-acting PrEP among MSM in six European Countries, October 2023-April 2024.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOral pre-exposure prophylaxis (PrEP) effectively prevents HIV but remains unevenly accessible across Europe. Long-acting PrEP (LA-PrEP), recently approved in Europe, offers new HIV protection options. However, no qualitative evidence is available to inform people's perceptions of this novel modality.
objectiveThis study provides the first large-scale, qualitative evidence in English from 20 European countries on how men who have sex with men (MSM) and trans* individuals perceive LA-PrEP.
methodsWe analyzed open-ended responses from 3123 HIV-negative MSM and trans* individuals from 20 European countries who completed the PROTECT survey in English. Participants were asked to describe what LA-PrEP means to them using words or short phrases. We used word clouds for initial insights and structural topic modeling to identify topics and explore their relevance across socioeconomic status, migration background, oral PrEP use, and affordability and the association of these perceptions with LA-PrEP intention.
resultsThe responses reflected generally positive associations toward LA-PrEP, with the most frequently mentioned word being "safe," "freedom," and "convenient." However, some ambivalent and negative perceptions, such as "nothing," "unknown," "dunno," and "unnecessary," were also noted. Structural topic modeling identified 5 main response topics: safety, empowerment, convenience/reliability, peace of mind, and concerns/uncertainties. The empowerment offered by LA-PrEP was the most prominent topic, representing one third (28.1%) of the responses, followed by safety (21%), convenience and reliability (16%), and peace of mind (15%), while concerns/uncertainties made up 20%. Variation in the relevance of these topics was found, showing LA-PrEP being seen as more empowering (=.070, 95% CI 0.042-0.097) and convenient (=.057, 95% CI 0.034-0.081) by current oral PrEP users, but less empowering (=-.052, 95% CI -0.087 to 0.017) and convenient (=-.034, 95% CI -0.064 to 0.005) for individuals in countries with limited oral PrEP access and affordability. The topic of safety was more relevant among those with lower levels of education (=.052, 95% CI 0.022-0.083) and those living in a country where PrEP was not reimbursed (=.035, 95% CI 0.002-0.069), but less relevant among current oral PrEP users (=-.094, 95% CI -0.12 to 0.066). We also found that ambivalent and negative perceptions were less relevant among current oral PrEP users (=-.032, 95% CI -0.056 to 0.007) and were negatively associated with a lower intention to use LA-PrEP (=-.075, 95% CI -0.101 to 0.005).
conclusionsOur research showed that MSM and trans* individuals in Europe generally have a positive outlook on LA-PrEP, suggesting it is likely to be well accepted upon its introduction in Europe. However, a subset of the target population may be hesitant to adopt LA-PrEP, underscoring the need for alternative HIV prevention strategies tailored to these individuals. To support potential future LA-PrEP implementation in Europe and to maximize its impact, appropriate communication strategies are essential for supporting informed decision-making.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.